Linezolid Aurobindo

Linezolid, the active ingredient in Linezolid Aurobindo, is an oxazolidinone presented as an injectable solution for intravenous use. It treats serious Gram‑positive bacterial infections, including MRSA, community‑acquired pneumonia, and skin and soft‑tissue infections, in adult patients when oral therapy is unsuitable.

GNH USA supplies Linezolid Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibiotic indicated for infections caused by susceptible Gram‑positive bacteria. It is employed in the following clinical situations: - Gram‑positive bacterial infections: provides bacteriostatic activity against a broad range of resistant strains. - Methicillin‑resistant Staphylococcus aureus (MRSA): effective for skin, soft‑tissue and invasive infections. - Community‑acquired pneumonia: used when typical first‑line agents are contraindicated or ineffective. - Skin and soft tissue infections: treats cellulitis, abscesses, and wound infections caused by susceptible organisms.

Adverse reactions may occur with linezolid therapy and are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduced hemoglobin levels. - Peripheral neuropathy: sensory disturbances, potentially irreversible. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: metabolic disturbance requiring urgent care. - Optic neuropathy: visual changes, may be permanent.

Before initiating linezolid, clinicians should consider several safety measures. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic dysfunction: assess liver enzymes periodically. - Hematologic monitoring: perform baseline and regular CBC to detect cytopenias. - Concomitant serotonergic drugs: avoid or monitor closely for serotonin syndrome. - Hypersensitivity: discontinue if allergic reactions develop. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Linezolid may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: potential serotonin syndrome. - Rifampin: may reduce linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, monitor INR. - Phenytoin and carbamazepine: enzyme inducers that can lower linezolid levels. - Oral contraceptives: possible reduction in efficacy, advise alternative contraception. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased bleeding risk, monitor closely.